Skip to content
PeptideSport

Provider review

KERNX Health review

A "founding rate" that nearly doubles once the founding period ends

KERNX Health's own pricing states a "founding rate" of $129/month for semaglutide, available for 60 days only, with the regular rate stated as $249/month once that period ends — a jump the introductory banner doesn't headline. Tirzepatide follows the same shape: $199/month founding, $299/month regular.

Verified August 2026

Straight talk: how we earn — some, not all, of these are affiliate links; start a program through one and we may earn a commission at no extra cost to you. Straight about the rest, too: the write-ups say what each provider is actually worth, and a commission does not change a word of them. Full disclosure here.

On this page

The verdict

KERNX Health LLC (Washington, DC) prices semaglutide at a $129/month "founding rate" (regular $249/month after the founding period) and tirzepatide at $199/month founding (regular $299/month), plus separate consultation fees layered on top — $25 for a message-based review, $35 for a standard live visit, or $60 for a complex one. It states coverage across all 50 states and names several providers (Laurie Mercier MD, Michael Wasef MD, and nurse practitioners) without designating a single medical director. Refunds are handled "on a case-by-case basis" rather than a stated policy.

KERNX Health is not ranked on any of our boards. This is a standalone read of what the company publishes about itself — the providers we do rank in this category are on our semaglutide provider ranking. Nothing on this page is a performance claim — see the evidence review for what these compounds do and do not do.

Who it is for, and who it is not

A good fit if

  • You're comfortable with the $129/$199 founding rate and plan to evaluate before it reverts to the regular $249/$299 rate
  • You want the option of a cheaper message-based review ($25) instead of a live visit
  • You don't need a single named medical director

Look elsewhere if

  • You want a price that holds steady rather than nearly doubling after an introductory period
  • You want a refund policy stated in advance rather than "case-by-case"
  • You want a specific pharmacy named rather than a generic "FDA-registered" claim

What it actually costs

What they advertise

Semaglutide $129/month "founding rate" (regular $249/month), tirzepatide $199/month founding (regular $299/month), per kernxhealth.com.

What you actually pay, month to month

The founding rate is real for the stated introductory period; the regular rate afterward is $249/month for semaglutide and $299/month for tirzepatide, nearly double in both cases.

The commitment trap

Founding-rate framing — the introductory price is available for 60 days only, after which it nearly doubles to the regular rate.

Money you will meet later

  • $25 for a message-based review, $35 for a standard live visit, or $60 for a complex live visit
  • Refunds are handled case-by-case rather than under a stated policy

Checked live on KERNX Health's own site at https://kernxhealth.com/ in August 2026. Prices change without notice — confirm before you buy. Work out what a vial actually gives you with our peptide dose calculator.

What is included

The cheapest headline number in this category is often the one with the least attached to it. Here is what KERNX Health bundles in, and what it does not.

Clinician consult

A licensed provider consultation is included at the base tier;…

live-visit fees apply for more complex reviews.

Bloodwork / labs

Not addressed in the sources read.

Follow-ups and dose changes

Monthly progress check-ins are advertised as included.

Human support

Messaging with the care team is included, per the homepage.

Injection supplies

Not itemized in the sources read.

Shipping

Discreet monthly delivery is included, per the homepage.

Pharmacy, labs and oversight

The pharmacy

Not named. Described only as "FDA-registered compounding pharmacies that meet strict quality and safety standards."

Oversight

A licensed provider consultation is included at the base tier; live-visit fees apply for more complex reviews. Monthly progress check-ins are advertised as included.

Compounded peptides are not FDA-approved products, and a 503A pharmacy compounds for a named patient while a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not. Our guide to verifying a certificate of analysis covers what to ask for.

Where you can get it

"All 50 States served through our licensed physician network," per the company's own claim.

The honest cons

The part they would rather you skipped

"Founding rate" is marketing language for a price that KERNX's own site states will roughly double — $129 to $249 for semaglutide, $199 to $299 for tirzepatide — after just 60 days, a window short enough that a reader who signs up expecting the founding price to hold could see it reset within two billing cycles.

  • The advertised rate nearly doubles after only 60 days
  • No specific pharmacy named
  • Refunds are handled case-by-case rather than under a stated policy
  • No single medical director named — several providers listed instead

None of this is unique to KERNX Health — the whole category shares it. What we hold against a provider is the part it hides, and the ways vendors hide things are catalogued in our vendor red-flags guide.

How it compares

Read this before you buy

A provider comparison is half the decision. The other half is whether the compound does anything for you at all — and whether it is allowed where you compete. Growth-hormone secretagogues are banned in tested sport, year-round, and a prescription does not change that.

Facts on this page reflect KERNX Health's own public disclosures when we last checked them, in August 2026. Prices and terms change without notice — confirm on KERNX Health's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved, and growth-hormone secretagogues are banned in tested sport year-round. See our disclosure and editorial policy.